Genetic variants near the MSMB locus, particularly rs10993994, are associated with changes in MSMB expression and increased risk of prostate cancer, with functional evidence indicating that regulatory variants reduce expression of MSMB, which may lessen their potential protective effects against tumorigenesis (24). Here, MSMB is linked to prostate carcinoma.